Cordis Archives - Cardiovascular News

From data to decisions: Advancing confidence in DEB therapy

13th May 2026

This educational suppleme...

TCT 2025: Selution SLR meets non-inferiority in de novo and in-stent restenosis trials

26th October 2025

Cordis has announced ...

US FDA approves Cordis’ Mynx Control venous vascular closure device

10th July 2024

Cordis recently announced...

Cordis announce positive 24-month results from Selution SFA Japan trial

19th June 2024

Cordis has announced posi...

MedAlliance to be acquired by Cordis

18th October 2022

MedAlliance is to be acqu...

Cordis launches Mynx Control vascular closure device in the USA

5th November 2018

Cordis, a Cardinal He...

First US commercial implants of Elunir drug-eluting stent performed

16th January 2018

Cordis and Medinol ha...

Elunir drug-eluting stent approved for use in the USA

30th November 2017

Cordis and Medinol ha...

Cordis granted CE mark for Railway sheathless access system

7th April 2017

Cordis has received t...

First US commercial case performed using Tryton Side branch stent

23rd March 2017

Tryton Medical has an...

FDA grants approval to Tryton for side-branch stent

7th March 2017

The US Food and Drug ...

Write to us
Editorial: Will Date will@bibamedical.com
Advertising: Hannah Shiels hannah@bibamedical.com

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: info@bibamedical.com

Terms and Conditions | Privacy Policy